November 15, 2012

Initial shipment of a generic appetite suppressant has started, the drug's manufacturer said Thursday.

November 5, 2012

The Food and Drug Administration has approved a generic drug for treating blood pressure and chest pain.

October 22, 2012

Watson Pharmaceuticals and Actavis will have to divest rights to almost two dozen drugs as a condition for U.S. regulatory approval of their $5.6 billion merger announced earlier this year, according to regulatory documents.

April 12, 2012

Valeant announced that it has acquired a privately owned specialty pharmaceutical company based in the United States.

April 21, 2011

GlaxoSmithKline and Valeant last week responded to the Food and Drug Administration's complete response letter for the companies' investigational anti-epileptic drug.